Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
Zahabia Adnan, Research Executive at Student Research Form-SMC, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I’m pleased to share our recently published systematic review and meta-analysis, ‘Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism,’ in Clinical and Applied Thrombosis/Hemostasis.
Analyzing data from 25 studies and 19,153 patients, our findings indicate that rivaroxaban was associated with a significant reduction in both VTE recurrence and all-cause mortality compared to low molecular weight heparin in patients with cancer-associated thrombosis.
These results contribute to the evolving evidence on anticoagulant selection in oncology and highlight the need for continued large-scale trials.
I’m grateful for the invaluable contributions of my co-authors for making this project successful.
Hoping to work on more projects too.
Do give a read to it.”
Title: Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
Authors: Zahabia Adnan, Syed Ibad Hussain, Amna Amir Jalal, Ayesha Shaukat, Eisha Abid, Muhammad Burhan, Arsalan Ahmed, Eshal Saghir, Shaikh Muhammad Daniyal, Shanza Shakir, Abedin Samadi, Ahmed Asad Raza
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience